2020 Annual Conference
The TAMEST 2020 Annual Conference: Innovating Texas explored how basic research leads to new technologies, products and companies and showcased avenues to commercialization for researchers across an array of disciplines. The program featured success stories from some of Texas’ greatest entrepreneurs and inventors and looked at astounding research and technology developments happening now that will impact our lives and economy in the future.
In January of each year, TAMEST hosts an annual conference where the state’s top researchers, corporate leaders and university presidents and chancellors can come together to discuss cutting edge research within a broad array of fields including life sciences, medicine, aerospace and energy.
While the topics for each conference varies year over year, the goal of each conference—being able to connect academia, industry, legislature and members—remains unchanged. Topics have included brain health, aerospace, sustainability, cancer, materials science and engineering and more.
Attendees include TAMEST members, their designated protégés and special invited guests. Learn more about past conferences below.
Investigating topics like mental health, healthy aging, neurological disease prevention, technological advances in mapping the brain and the neuroscience research priorities and challenges ahead.
Exploring the potential in Texas for greater research and development in aerospace, specifically in the areas of human space flight, aeronautics and commercial space exploration.
Examining key issues like energy, health, water and transportation and the challenges we face ensuring an equitable, efficient supply of them in the coming century.
Highlighting recent developments in materials science and engineering that are and will be leading to qualitative changes in the way products are manufactured, the way medicine is practiced and the way energy is provided to our society.
Focusing on cancer research, encompassing highlights of current problems, new mechanistic information, technology and therapeutic considerations for a disease that is now the second leading cause of death in the United States.